Evidence map›Paper›PMID 33083442›Full record

ArticleERJ open research2020

Bronchoscopically delivered microwave ablation in an

Jan Sebek, Steve Kramer, Rob Rocha, Kun-Chang Yu, Radoslav Bortel, Warren L Beard, David S Biller, David S Hodgson, Charan K Ganta, Henky Wibowo and 4 more

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Advanced Imaging for Robotic Bronchoscopy: A Review.Diagnostics (Basel, Switzerland) · 2023
    Review
  6. Novel Image-Guided Flexible-Probe Transbronchial Microwave Ablation for Stage 1 Lung Cancer.Respiration; international review of thoracic diseases · 2023
    Article
  7. The Latest on Lung Ablation.Seminars in interventional radiology · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Jan SebekDept of Electrical and Computer Engineering, Kansas State University Manhattan, Manhattan, KS, USA.
Steve KramerBroncus Medical, Inc., San Jose, CA, USA.
Rob RochaBroncus Medical, Inc., San Jose, CA, USA.
Kun-Chang YuBroncus Medical, Inc., San Jose, CA, USA.
Radoslav BortelDept of Circuit Theory, Czech Technical University in Prague, Prague, Czech Republic.
Warren L BeardDept of Clinical Sciences, Kansas State University, Manhattan, KS, USA.
David S BillerDept of Clinical Sciences, Kansas State University, Manhattan, KS, USA.
David S HodgsonDept of Clinical Sciences, Kansas State University, Manhattan, KS, USA.
Charan K GantaDept of Diagnostic Medicine/Pathobiology, Kansas State University, Manhattan, KS, USA.
Henky WibowoPhenomapper, LLC., San Jose, CA, USA.
John YeeDept of Thoracic Surgery, Vancouver General Hospital and the University of British Columbia, Vancouver, Canada.
Renelle MyersDept of Thoracic Surgery, Vancouver General Hospital and the University of British Columbia, Vancouver, Canada.
Stephen LamDept of Integrative Oncology, BC Cancer Research Center and the University of British Columbia, Vancouver, Canada.
Punit PrakashDept of Electrical and Computer Engineering, Kansas State University Manhattan, Manhattan, KS, USA.
Kansas State University · USBroncus (United States) · USCzech Technical University in Prague · CZUniversity of British Columbia · CAVancouver General Hospital · CA

Funding

Bronchoscope-guided microwave ablation of early-stage lung tumorsR01CA218357 · NCI · KANSAS STATE UNIVERSITY · PI PRAKASH, PUNIT · 2018 to 2022
$1.3M
NCI NIH HHS R01 CA218357
6 · The paper itself

Abstract

backgroundPercutaneous microwave ablation is clinically used for inoperable lung tumour treatment. Delivery of microwave ablation applicators to tumour sites within lung parenchyma under virtual bronchoscopy guidance may enable ablation with reduced risk of pneumothorax, providing a minimally invasive treatment of early-stage tumours, which are increasingly detected with computed tomography (CT) screening. The objective of this study was to integrate a custom microwave ablation platform, incorporating a flexible applicator, with a clinically established virtual bronchoscopy guidance system, and to assess technical feasibility for safely creating localised thermal ablations in porcine lungs

methodsPre-ablation CTs of normal pigs were acquired to create a virtual model of the lungs, including airways and significant blood vessels. Virtual bronchoscopy-guided microwave ablation procedures were performed with 24-32 W power (at the applicator distal tip) delivered for 5-10 mins. A total of eight ablations were performed in three pigs. Post-treatment CT images were acquired to assess the extent of damage and ablation zones were further evaluated with viability stains and histopathologic analysis.

resultsThe flexible microwave applicators were delivered to ablation sites within lung parenchyma 5-24 mm from the airway wall

conclusionWe have demonstrated the technical feasibility for safely delivering microwave ablation in the lung parenchyma under virtual bronchoscopic guidance in an

Identifiers

PMID33083442
PMCPMC7553114
OpenAlexW3093185831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.